• 제목/요약/키워드: Selena

검색결과 4건 처리시간 0.022초

Effect of belimumab in patients with systemic lupus erythematosus treated with low dose or no corticosteroids

  • Yeo-Jin Lee;Soo Min Ahn;Seokchan Hong;Ji-Seon Oh;Chang-Keun Lee;Bin Yoo;Yong-Gil Kim
    • The Korean journal of internal medicine
    • /
    • 제39권2호
    • /
    • pp.338-346
    • /
    • 2024
  • Background/Aims: Systemic lupus erythematosus (SLE) responder index (SRI)-4 response has been achieved with belimumab treatment in patients with moderate disease activity in cornerstone clinical trials and following studies. However, most studies involved patients treated with a mean prednisolone-equivalent dose of approximately 10 mg/d and focused on the steroid-sparing effect of belimumab. We aimed to identify the effect of belimumab in patients with mild-to-moderate SLE who were treated with low-dose or no corticosteroids. Methods: We retrospectively reviewed the electronic medical records of patients treated with belimumab for at least 6 months between May 2021 and June 2022. The primary endpoint was SRI-4 response at 6 months. Results: Thirty-one patients were included (13 low dose- and 18 steroid non-users). The mean age was 39.2 ± 11.4 years, and 90.3% of patients were female. The baseline Safety of Estrogens in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index (SELENA-SLEDAI) score was 6.0 (4.0-9.0). The primary endpoint was achieved in 32.3% (10/31) of patients. Significant improvements in anemia, C4 levels, and SELENA-SLEDAI score were observed during treatment. Univariate analysis showed that the baseline SELENA-SLEDAI and arthritis were significantly associated with SRI-4 response at 6 months, and only the SELENA-SLEDAI remained significant (p = 0.014) in multivariate analysis. Conclusions: This cohort study is the first to report the efficacy of belimumab after minimizing the effect of corticosteroids. Belimumab showed efficacy in improving the SELENA-SLEDAI score, anemia, and low C4 in patients who did not receive corticosteroids or received only low doses.

라티노성(Latinidad) 논의의 사례와 의미 - 라틴 음악을 중심으로 (Rethinking Latinidad in Latin Music)

  • 이은아
    • 비교문화연구
    • /
    • 제23권
    • /
    • pp.295-319
    • /
    • 2011
  • This study examines how Latinidad can be reclaimed as a site for exploring affinities of Latinos in Latin music industry, especially from the 90s. By looking at sites where Latinidad is constituted, such as the case of Jennifer $L{\acute{o}}pez$ becoming Selena, it intends to suggest that the concept can be deployed as a political bridge to connect latinos. And by examining Cuban-American artists' self identification in Latin Grammy Awards, it reveals that the latin music business definitions of Latinidad is coded differently for them as 'Caribbean' to erase a natural resonance of Cuba. In addition, by dealing with Shakira's somewhat contradictory representation of Colombianidad, the study argues that Latinidad serves as a social construct and newly emerges as a convenient interstitial place between the Latin American and the US Latino. Shakira's case serves to show how the transnational trends of latin music contribute to create a simultaneous sense of Latinidad and Colombianidad. Focusing on the commercial significance of understanding of what latino is or should be, this paper aims to interrogate current understandings of Latinidad in the realm of latin music and popular culture.

Synthesis of New Uraci1-5-Sulphonamide-p-Phenyl Derivatives and Their Effect on Biomphalaria alexandrina Snail's Nucleoproteins

  • Fathalla, O.A.;Gad, H.S.M.;Maghaby, A.S.
    • Archives of Pharmacal Research
    • /
    • 제23권2호
    • /
    • pp.128-138
    • /
    • 2000
  • In continuation of the previous work (Fathalla, 1992) on the synthesis of some heterocycles containing uracil moiety, we report herein the incorporation of uracil moiety into cyan-opyridine thione, thiosemecarbazone, semicarbazone, cyanopyridine, ami nocyano pyridine, isoxazoline, pyrazoline, pyrimidine, triazolo pyrimidine, pyran, selena and thiazole derivatives which might modify their biological activities. The biological studies revealed that the chemical compound III f showed high molluscicdal activity than other compounds. The profile of the nucleoprotein extracted from chemically (compound IIIc, e, f and g) treated or UV-irradiated B.alexandrina snails did not show appreciable differences when compared to non-treated (native) snails by using SDS-PAGE, where no obvious qualitative or quantitative differences were observed. Immunization of experimental animals with the nucleoprotein extracted from native, chemically (compound III f & g) treated or physically treated B.alexandrina snails induced significant protection against challenge with normal S.mansoni cercariae, as compared to the non-immunized challenged control. As well as , a decrease in the number of granuloma formation and the size range of granuloma was also observed in immunized animals. It is concluded that, compounds III f and g have a potent molluscicidal activity. They also induced chemical modification comparable to that induced by physical treatment in the snail's nucleoprotein, which could possibly be used in immunization against S. mansoni infection.

  • PDF